Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kymera Therapeutics Inc 500 North Beacon Street 4th Floor Watertown MA 02472 USA

www.kymeratx.com P: 857-285-5300

Description:

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,644,530
Enterprise Value, $K 2,534,560
Shares Outstanding, K 61,358
Annual Sales, $ 78,590 K
Annual Net Income, $ -146,960 K
Last Quarter Sales, $ 10,290 K
Last Quarter Net Income, $ -48,560 K
EBIT, $ -178,030 K
EBITDA, $ -179,690 K
60-Month Beta 2.22
% of Insider Shareholders 15.82%
Float, K 51,651
% Float 84.18%
Short Volume Ratio 0.60

Growth:

1-Year Return 97.34%
3-Year Return -25.88%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.69 on 05/02/24
Next Earnings Date 08/01/24
Earnings Per Share ttm -2.51
EPS Growth vs. Prev Qtr -176.00%
EPS Growth vs. Prev Year 1.43%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KYMR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -31.92%
Return-on-Assets % -23.98%
Profit Margin % -187.00%
Debt/Equity 0.00
Price/Sales 34.20
Price/Cash Flow N/A
Price/Book 3.78
Book Value/Share 11.59
Interest Coverage -733.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar